Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The Ginema study reported by Bucaneve and colleagues recruited for a formal, double-blind, randomized placebo controlled trial of 500 mg/d levofloxacin among 760 patients who were admitted to the hospital and who were at risk of developing neutropenia resulting from treatment of acute leukemia lymphoma or solid tumors.

Antibacterial Prophylaxis for Patients with Cancer: Should We Use It or Not?